科研动态PubMed 摘要

认知行为疗法对帕金森病患者焦虑和抑郁症状的疗效:一项系统综述和荟萃分析。

PubMed 学科轮询 · 2026-11-05

完整摘要 · 中文译文

背景:焦虑和抑郁是帕金森病(PD)中高度普遍的非运动症状,严重损害健康相关生活质量。传统药物管理常受到不良反应、多重用药和药代动力学相互作用的限制。认知行为疗法(CBT)代表一种有前景的结构化非药物策略,但有必要对临床试验证据进行更新的、全面的综合。 目的:系统评价CBT缓解PD患者焦虑和抑郁症状的疗效及临床安全性特征。 方法:按照PRISMA 2020指南开展随机对照试验(RCT)的系统综述和荟萃分析。检索PubMed、Embase、Cochrane Library和Web of Science,检索时间自数据库建库至2025年10月。纳入评估CBT(≥4次会话,持续≥4周)对照对照条件(如常规治疗、等待名单、主动对照)在伴有焦虑和/或抑郁结局的PD成人中效果的RCT。两名评价者独立筛选文献、提取数据,并使用Cochrane偏倚风险工具评估方法学质量。采用随机效应模型合并标准化均数差(SMD)及其95%置信区间(CI)。进行了亚组、敏感性和发表偏倚分析。 结果:共纳入21项RCT,包括892例PD患者(CBT:n = 465;对照:n = 427)。荟萃分析显示,CBT与统计学显著的 焦虑症状的减轻(16项研究;SMD = -0.66,95% CI -0.83至-0.50;P < 0.001;I2 = 79.1%)和抑郁症状的减轻(14项研究;SMD = -0.61,95% CI -0.78至-0.44;P < 0.001;I2 = 86.6%)。亚组分析表明,持续时间超过10周的干预以及使用适应人群的量表(如GAI、GDS)进行评估时,治疗效果增强。留一法敏感性分析证实了合并估计的稳健性,Egger检验未发现显著的发表偏倚。 结论:认知行为疗法(CBT)可显著且具有临床意义地减轻帕金森病患者的焦虑和抑郁症状。尽管研究间存在显著异质性且干预实施方式存在差异,结构化CBT仍应被推荐为帕金森病多学科综合管理的组成部分。有必要开展更大规模的多中心随机对照试验(RCT),采用标准化的疾病特异性核心结局指标集并进行更长时间的随访。

完整摘要 · 英文原文

BACKGROUND: Anxiety and depression are highly prevalent non-motor symptoms in Parkinson's disease (PD), severely compromising health-related quality of life. Conventional pharmacological management is frequently constrained by adverse effects, polypharmacy, and pharmacokinetic interactions. Cognitive Behavioral Therapy (CBT) represents a promising structured non-pharmacological strategy, but an updated, comprehensive synthesis of clinical trial evidence is warranted. OBJECTIVE: To systematically evaluate the efficacy and clinical safety profile of CBT for alleviating anxiety and depressive symptoms in patients with PD. METHODS: A systematic review and meta-analysis of randomized controlled trials (RCTs) was conducted in accordance with the PRISMA 2020 guidelines. PubMed, Embase, the Cochrane Library, and Web of Science were searched from database inception to October 2025. RCTs evaluating CBT (≥ 4 sessions over ≥ 4 weeks) versus control conditions (e.g., treatment as usual, waitlist, active controls) in adults with PD reporting anxiety and/or depression outcomes were included. Two reviewers independently screened literature, extracted data, and assessed methodological quality using the Cochrane Risk of Bias tool. Standardized mean differences (SMDs) with 95% confidence intervals (CIs) were pooled via random-effects models. Subgroup, sensitivity, and publication bias analyses were performed. RESULTS: Twenty-one RCTs comprising 892 patients with PD (CBT: n = 465; control: n = 427) were included. Meta-analysis demonstrated that CBT was associated with statistically significant reductions in anxiety symptoms (16 studies; SMD = -0.66, 95% CI -0.83 to -0.50; P < 0.001; I2 = 79.1%) and depressive symptoms (14 studies; SMD = -0.61, 95% CI -0.78 to -0.44; P < 0.001; I2 = 86.6%). Subgroup analyses indicated enhanced therapeutic effects in interventions with durations exceeding 10 weeks and when evaluated using population-adapted instruments (e.g., GAI, GDS). Leave-one-out sensitivity analyses confirmed the robustness of pooled estimates, and Egger's tests revealed no significant publication bias. CONCLUSION: CBT produces significant, clinically meaningful reductions in anxiety and depressive symptoms in patients with Parkinson's disease. Despite substantial between-study heterogeneity and variations in intervention delivery, structured CBT should be recommended as an integral component of multidisciplinary PD care. Larger multicenter RCTs with standardized disease-specific core outcome sets and longer follow-up are warranted.

English
Efficacy of cognitive behavioral therapy for anxiety and depression symptoms in Parkinson's disease patients: a systematic review and meta-analysis.
内容仅供参考,不构成诊疗建议,不能替代执业医师的诊断。

← 返回元界